Beirut, Lebanon Clinical Trials

A listing of Beirut, Lebanon clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 81 clinical trials
A Study Investigate the Safety Tolerability Pharmacokinetic and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome

This study will investigate the safety and tolerability of SLN124 in patients with Thalassaemia or patients with Very Low- and Low-risk Myelodysplastic Syndrome after single ascending s.c. doses and multiple doses in healthy male and female subjects. Up to 7 cohorts of 56 patients with Thalassaemia and up to 7 …

 (41.8 away) Contact site
  • 22 Mar, 2021
  • +13 other locations
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease

The objectives of this study are to evaluate the efficacy, safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06651600 (200 mg for 8 weeks followed by 50 mg for 4 weeks) dosed once daily and PF-06700841 (60 mg for 12 weeks) dosed once daily during an induction period of 12 weeks, followed …

tumor necrosis factor
crohn's disease
certolizumab pegol
H tel Dieu de France Hospital
 (1.1 away) Contact site
  • 24 May, 2021
  • +296 other locations
Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

To compare the combination of Ribociclib plus goserelin acetate with hormonal therapy versus combination chemotherapy in premenopausal or perimenopausal patients with advanced or metastatic breast cancer

advanced breast cancer
gonadotropin releasing hormone
chromogenic in situ hybridization
Novartis Investigative Site
 (0.8 away) Contact site
  • 11 Jun, 2021
  • +39 other locations
Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)

The study is conducted to improve knowledge about the epidemiology of Lipoprotein(a) in patients with established cardiovascular disease (CVD).

Novartis Investigative Site
 (3.3 away) Contact site
  • 27 May, 2021
  • +750 other locations
Safety Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy

Nidufexor addresses fibrosis, oxidative stress, inflammation and cell death, and therefore has the potential to improve the management of diabetic kidney disease when added to the standard of care (angiotensin converting enzyme inhibitor or angiotensin receptor blocker). This non-confirmatory Phase 2 study is designed to determine the safety, tolerability, efficacy, …

type 2 diabetes mellitus
diabetic nephropathy
Novartis Investigative Site
 (1.1 away) Contact site
  • 25 Apr, 2021
  • +22 other locations
Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sickle cell disease (SCD) patients with history of vaso-occlusive crisis (VOC) leading to healthcare visit.

vaso-occlusive crisis
absolute neutrophil count
conjugated bilirubin
Novartis Investigative Site
 (41.8 away) Contact site
  • 10 Jun, 2021
  • +86 other locations
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)

The purpose of this study is to determine if the investigational treatment (maralixibat) is safe and effective in pediatric participants with Progressive Familial Intrahepatic Cholestasis (PFIC).

Ankara University Faculty of Medicine, Turkey
 (440.3 away) Contact site
  • 08 Apr, 2021
  • +78 other locations
Phase 1 Pediatric Pharmacokinetics/Pharmacodynamics (PK/PD) Study

This is the first evaluation of edoxaban in pediatric subjects. In this Phase 1 study, a single dose of edoxaban will be given to pediatric subjects who require anticoagulant therapy to see what the body does to the drug (pharmacokinetics) and what the drug does to the body (pharmacodynamics), and …

anticoagulant therapy
Hammoud Hospital University Medical Center
 (24.3 away) Contact site
  • 14 Jun, 2021
  • +40 other locations
Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

This is an event driven Phase 3, prospective, randomized, open-label, blinded endpoint evaluation (PROBE) parallel group study in subjects with confirmed VTE. This study is designed to evaluate the pharmacokinetics (PK) and pharmacodynamics (PD) of edoxaban and to compare the efficacy and safety of edoxaban against standard of care in …

vitamin k
anticoagulant therapy
heparin therapy
vitamin k antagonist
Saint George University Hospital Medical Center
 (0.5 away) Contact site
  • 28 Jan, 2021
  • +169 other locations
A Research Study to Compare a New Medicine Oral Semaglutide to a Dummy Medicine in Children and Teenagers With Type 2 Diabetes

This study compares 2 medicines for type 2 diabetes: semaglutide (new medicine) and a dummy medicine (placebo). Semaglutide will be tested to see how well it works compared to the dummy medicine. The study will also test if semaglutide is safe in children and teenagers. Participants will either get semaglutide …

Novo Nordisk Investigational Site
 (3.3 away) Contact site
  • 16 Jun, 2021
  • +55 other locations